FDA Authorizes Libre Duo: Continuous Glucose and Ketone Monitoring Explained
Det gick inte att lägga till artiklar
Titeln kunde inte läggas till i kundvagnen.
Titeln kunde inte läggas till i Önskelistan.
„Ta bort från Önskelista“ misslyckades.
„Följ podcast“ misslyckades
„Sluta följa podcast“ misslyckades
FDA Authorizes Libre Duo: Continuous Glucose and Ketone Monitoring Explained
-
Berättare:
-
Av:
The FDA has authorized Libre Duo, a wearable sensor designed to monitor glucose and ketones continuously for people with diabetes aged two years and older.
This Medical News Update explains how the system works, why rising ketones matter, its potential role in detecting diabetic ketoacidosis risk, and the important limitations patients and caregivers should understand. Continuous monitoring supports, but does not replace, a written sick-day plan, backup ketone testing, or urgent medical care when warning symptoms develop.
Read the full patient-friendly article:
https://livingdiabetes.com/fda-libre-duo-continuous-glucose-ketone-monitoring/
For general education only. This episode does not replace individualized medical advice, product instructions, or emergency care.